Association of CD40 SNPs with Moyamoya in a Chinese children population

Research Progresses in Understanding the Pathophysiology of Moyamoya Disease

(2016) Anna Bersano et al.   CEREBROVASCULAR DISEASES

Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease

(2016) Jian-Bin Chen et al.   JOURNAL OF NEUROSURGERY

Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance

(2015) David F Pinelli et al.   Immunotherapy

A new horizon of moyamoya disease and associated health risks explored through RNF213

(2015) Akio Koizumi et al.   Environmental Health and Preventive Medicine

The Contribution of CD40/CD40L Axis in Inflammatory Bowel Disease: An Update

(2015) Nezha Senhaji et al.   Frontiers in Immunology

Loss of α1β1 Soluble Guanylate Cyclase, the Major Nitric Oxide Receptor, Leads to Moyamoya and Achalasia

(2014) Dominique Hervé et al.   AMERICAN JOURNAL OF HUMAN GENETICS

The GC + CC genotype at position -418 in TIMP-2 promoter and the -1575GA/-1306CC genotype in MMP-2is genetic predisposing factors for prevalence of moyamoya disease

(2014) Young Seok Park et al.   BMC Neurology

TLR–CD40 Cross-Talk in Anti-Leishmanial Immune Response

(2014) Himanshu Singh Chandel et al.   Frontiers in Immunology

Understanding the influence of the tumor microenvironment on macrophage responses to CD40 agonists

(2014) Nadia Luheshi et al.   OncoImmunology

Guidelines for Diagnosis and Treatment of Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis)

(2013) et al.   NEUROLOGIA MEDICO-CHIRURGICA

Replication and Meta-Analysis of GWAS Identified Susceptibility Loci in Kawasaki Disease Confirm the Importance of B Lymphoid Tyrosine Kinase (BLK) in Disease Susceptibility

(2013) Chia-Jung Chang et al.   PLoS One

Moyamoya Disease in a Primarily White, Midwestern US Population

(2013) Regina S. Bower et al.   STROKE

Is There a Role for Treating Inflammation in Moyamoya Disease?: A Review of Histopathology, Genetics, and Signaling Cascades

(2013) Adam M. H. Young et al.   Frontiers in Neurology

CD40Gene Polymorphisms Associated with Susceptibility and Coronary Artery Lesions of Kawasaki Disease in the Taiwanese Population

(2012) Ho-Chang Kuo et al.   TheScientificWorldJOURNAL

The CD40-CD40L system in cardiovascular disease

(2011) Burak Pamukcu et al.   ANNALS OF MEDICINE

Identification of Novel Susceptibility Loci for Kawasaki Disease in a Han Chinese Population by a Genome-Wide Association Study

(2011) Fuu-Jen Tsai et al.   PLoS One

Increased Thyroid Function and Elevated Thyroid Autoantibodies in Pediatric Patients With Moyamoya Disease

(2011) Hao Li et al.   STROKE

Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients

(2010) Constantin Roder et al.   ACTA NEUROCHIRURGICA

Common genetic polymorphisms in Moyamoya and atherosclerotic disease in Europeans

(2010) Constantin Roder et al.   CHILDS NERVOUS SYSTEM

Diffuse and uncontrolled vascular smooth muscle cell proliferation in rapidly progressing pediatric moyamoya disease

(2010) Amy J. Reid et al.   Journal of Neurosurgery-Pediatrics

Moyamoya: Epidemiology, Presentation, and Diagnosis

(2010) Edward R. Smith et al.   NEUROSURGERY CLINICS OF NORTH AMERICA

Coronary artery fistula associated with Kawasaki disease

(2009) Chi-Di Liang et al.   AMERICAN HEART JOURNAL

Pathophysiology and genetic factors in moyamoya disease

(2009) Achal S. Achrol et al.   Neurosurgical Focus

Association of Thyroid Autoantibodies With Moyamoya-Type Cerebrovascular Disease

(2009) Suk Jae Kim et al.   STROKE